Xcout Intel
Portal Biotechnologies, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Portal Biotechnologies, Inc. among healthcare companies — ranked by similarity to what Portal Biotechnologies, Inc. actually does, not by market-cap band.
Subscribe to see Portal Biotechnologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Portal Biotechnologies, Inc.
Portal Biotechnologies, Inc. was founded in 2023 and is headquartered in Watertown, Massachusetts, focusing on advanced cell engineering techniques and drug discovery platforms.
Portal Biotechnologies, Inc. at a glance
Portal Biotechnologies, Inc. is a healthcare company headquartered in United States. It has raised at least $59.9M across the 6 funding rounds on record. Its most recent funding round raised $9M in June 2026. Xcout tracks 9 named people at Portal Biotechnologies, Inc., including Julie Kim (Chief of Staff to the CEO).
Portal Biotechnologies, Inc. leadership
- Julie KimChief of Staff to the CEO
- Andy Heronco-founder and CEO
- Armon Sharei, Ph.DFounder and CEO
- Alec BarclayCo-Founder & COO
- Catherine HoganVP, Operations
- Christalyn Rhodes, MBA, Ph.D.Head of Translational Strategy
3 more named people on record for Portal Biotechnologies, Inc., with roles, board committees and tenure — see the full roster →
Portal Biotechnologies, Inc. funding rounds
At least $59.9M raised across the 6 rounds on record. The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $9M | 6 named | |
| Seed | $10.5M | 6 named | |
| Seed | $12M | 6 named | |
| SEC Form D filing | $11.7M | — | |
| Series A | $11.7M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Portal Biotechnologies, Inc. competitors
Ranked by semantic similarity — how close each company is to Portal Biotechnologies, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
CytoTronics is a biotechnology research company headquartered in Boston, Massachusetts, specializing in cell-based discovery and high-density electrode array technology.
Biotech
Ginkgo Bioworks Holdings, Inc., alongside its subsidiary entities, provides an advanced technological platform focused on the engineering of cells. This proprietary system is utilized to manipulate cellular functions, facilitating the biological creation of various products. These outputs span from innovative pharmaceutical treatments and vital food components to sustainable chemicals designed to replace those traditionally sourced from petroleum. The enterprise caters to a broad spectrum of industries, encompassing specialized chemical manufacturing, the agricultural sector, food production, consumer goods, and pharmaceuticals. Furthermore, Ginkgo Bioworks has forged a partnership with Selecta Biosciences, Inc., for the joint advancement of the ImmTOR technology platform. The company, founded in 2008, is headquartered in Boston, Massachusetts.
Biotechnology
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Biotech, Life Sciences & TechBio
Kytopen Corp. is a biotechnology company focused on cell therapy discovery, with facilities located in Cambridge, Massachusetts, and Louisville, Colorado, as well as an international expansion in Germany.
Biotech
Ginkgo Bioworks is a biotechnology research company headquartered in Boston, Massachusetts, that provides autonomous lab platforms for automated biological experiments.
Similar healthcare company
OneThree Biotech, Inc. is a New York City-based biotechnology company founded in 2018. The company develops an artificial intelligence-driven discovery platform designed to accelerate drug discovery and development by predicting novel targets, identifying patient-specific biomarkers, and finding drug candidates for repurposing.
Biotech
Dyno Therapeutics is a biotechnology research company headquartered in Watertown, Massachusetts, specializing in gene therapy delivery solutions using artificial intelligence.
Biotech
Photys Therapeutics, Inc. is a proximity-based biotechnology holding company founded in 2021 and headquartered in Massachusetts, United States. The company focuses on discovering and developing novel targeted protein therapeutics.
Biotech
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Biotechnology
Aperture Therapeutics is a biotechnology research company founded in 2022 and headquartered in San Carlos, California. The company is building an innovative drug discovery platform that leverages patient genetic diversity and mechanistic insights.
Biotech
Remix Therapeutics, Inc. is a biotechnology company headquartered in Watertown, Massachusetts. The company specializes in developing novel therapies that alter RNA processing to address serious diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Portal Biotechnologies, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Portal Biotechnologies, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →